(Q50787675)
Statements
Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan. (English)
1 reference
Scott D Ramsey
1 reference
Lauren Clarke
1 reference
Tripthi V Kamath
1 reference
Deborah Lubeck
1 reference
1 July 2006
1 reference
12
1 reference
6
1 reference
472-478
1 reference